Nafees Malik
Corporate Officer/Principal chez Juvenescence, Inc.
Profil
Nafees N.
Malik was the founder of Asklepian Consulting Ltd.
founded in 2013, where he held the title of Managing Director.
Currently, he is the Head-Cell & Gene Therapy at Juvenescence, Inc. since 2018.
He was the Chief Operating Officer at AgeX Therapeutics, Inc. from 2018 to 2023.
Dr. Malik holds a doctorate degree from The University of Liverpool and a graduate degree from the University of Cambridge.
Postes actifs de Nafees Malik
| Sociétés | Poste | Début |
|---|---|---|
| Juvenescence, Inc. | Corporate Officer/Principal | 01/10/2018 |
Anciens postes connus de Nafees Malik
| Sociétés | Poste | Fin |
|---|---|---|
| AGEX THERAPEUTICS, INC. | Chief Operating Officer | 27/12/2023 |
| Asklepian Consulting Ltd. | Chief Executive Officer | - |
Formation de Nafees Malik
| The University of Liverpool | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
| Juvenescence, Inc. | Miscellaneous |
| Asklepian Consulting Ltd. |
